Gluten sensitivity and epilepsy: a systematic review Thomas JulianMarios HadjivassiliouPanagiotis Zis Review Open access 23 August 2018 Pages: 1557 - 1565
Ocular amyloid imaging at the crossroad of Alzheimer’s disease and age-related macular degeneration: implications for diagnosis and therapy Sally S. OngAlan D. ProiaEleonora M. Lad Review 28 August 2018 Pages: 1566 - 1577
Cerebellar functional abnormalities in early stage drug-naïve and medicated Parkinson’s disease Shuai XuXin-Wei HeXiaoxia Du Original Communication 28 March 2019 Pages: 1578 - 1587
Thrombocytopenia and declines in platelet counts: predictors of mortality and outcome after mechanical thrombectomy Sebastian MönchTobias Boeckh-BehrensBenjamin Friedrich Original Communication 27 March 2019 Pages: 1588 - 1595
Rituximab as induction therapy in refractory myasthenia gravis: 18 month follow-up study Nishita SinghVinay Goyal Original Communication 27 March 2019 Pages: 1596 - 1600
Olfactory anosognosia is a predictor of cognitive decline and dementia conversion in Parkinson’s disease Han Soo YooSeok Jong ChungPhil Hyu Lee Original Communication 22 April 2019 Pages: 1601 - 1610
15-White Dots APP-Coo-Test: a reliable touch-screen application for assessing upper limb movement impairment in patients with cerebellar ataxias Giuseppe ArcuriaChristian MarcotulliCarlo Casali Original Communication 06 April 2019 Pages: 1611 - 1622
Strength and muscle structure preserved during long-term therapy in a patient with hypokalemic periodic paralysis (Cav1.1-R1239G) Marc-André WeberKarin Jurkat-RottFrank Lehmann-Horn Original Communication 01 April 2019 Pages: 1623 - 1632
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study Andrea CalvoAdriano ChiòMario G. Rizzone Original Communication 04 April 2019 Pages: 1633 - 1642
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis Sara MariottoAlberto GajofattoSergio Ferrari Original Communication 03 April 2019 Pages: 1643 - 1648
A novel COL6A2 mutation causing late-onset limb-girdle muscular dystrophy Manu JokelaSara LehtinenBjarne Udd Original Communication Open access 08 April 2019 Pages: 1649 - 1654
Antecedent infections in Fisher syndrome: sources of variation in clinical characteristics Michiaki KogaMasahiko KishiTakashi Kanda Original Communication Open access 06 April 2019 Pages: 1655 - 1662
In search of distinct MS-related fatigue subtypes: results from a multi-cohort analysis in 1.403 MS patients Gesa E. A. PustJana PöttgenIris-Katharina Penner Original Communication 19 April 2019 Pages: 1663 - 1673
Diagnosis strategy and Yacovino maneuver for anterior canal-benign paroxysmal positional vertigo Xu YangXia LingJi-Soo Kim Original Communication 08 April 2019 Pages: 1674 - 1684
Amyloid PETs are commonly negative in suspected Alzheimer’s disease with an increase in CSF phosphorylated-tau protein concentration but an Aβ42 concentration in the very high range: a prospective study Chloé MancaThérèse Rivasseau JonveauxAntoine Verger Original Communication 08 April 2019 Pages: 1685 - 1692
High-intensity training in patients with spinal and bulbar muscular atrophy Karen HejeGrete AndersenJohn Vissing Original Communication 19 April 2019 Pages: 1693 - 1697
Financial capacity in frontotemporal dementia and related presentations Sascha GillMervin BlairElizabeth Finger Original Communication Open access 22 April 2019 Pages: 1698 - 1707
Occurrence of cerebral small vessel disease at diagnosis of MPO-ANCA-associated vasculitis Hiroki TaniKoji NagaiShigeki Arawaka Original Communication 13 April 2019 Pages: 1708 - 1715
Structural correlates of attention dysfunction in Lewy body dementia and Alzheimer’s disease: an ex-Gaussian analysis Julia SchumacherRuth CromartyJohn-Paul Taylor Original Communication Open access 21 April 2019 Pages: 1716 - 1726
Motor, cognitive and behavioral differences in MDS PSP phenotypes Marina PicilloSofia CuocoThe PSP Salerno study group Original Communication 15 April 2019 Pages: 1727 - 1735
Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson’s disease Daniel J. van WamelenValentina LetaKallol Ray Chaudhuri Original Communication Open access 17 April 2019 Pages: 1736 - 1742
Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions Xavier AyrignacValérie RigauStéphane Kremer Original Communication 23 April 2019 Pages: 1743 - 1755
Parkinson’s-adapted cognitive stimulation therapy: feasibility and acceptability in Lewy body spectrum disorders Sheree A. McCormickSabina VatterIracema Leroi Original Communication Open access 04 June 2019 Pages: 1756 - 1770
Classification of degenerative parkinsonism subtypes by support-vector-machine analysis and striatal 123I-FP-CIT indices Nicolas NicastroJennifer WegrzykPierre R. Burkhard Original Communication Open access 29 April 2019 Pages: 1771 - 1781
Primary involvement of neurovascular coupling in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy Andrea Jokumsen-CabralAna AiresPedro Castro Original Communication 26 April 2019 Pages: 1782 - 1788
Seizures and epilepsy in multiple sclerosis: epidemiology and prognosis in a large tertiary referral center Lisa LangenbruchJulia KrämerStjepana Kovac Original Communication 08 May 2019 Pages: 1789 - 1795
SNCA but not DNM3 and GAK modifies age at onset of LRRK2-related Parkinson’s disease in Chinese population Zhi-hua YangYu-sheng LiYu-ming Xu Original Communication 30 April 2019 Pages: 1796 - 1800
Livedo racemosa generalisata: an anthological vision through Vladímir Lébedev painting José Berciano Letter to the Editors 04 April 2019 Pages: 1801 - 1802
Obituary for Prof. Dr. Dr. h.c. Dipl. Ing. Frank Lehmann-Horn Holger LercheKarin Jurkat-RottMarc-André Weber Letter to the Editors 05 April 2019 Pages: 1803 - 1803
Anti-natalizumab antibodies during 8 years of natalizumab treatment: effect on natalizumab concentration and α4-integrin receptor saturation Zoé L. E. van KempenJohannis A. van RossumJoep Killestein Letter to the Editors 19 April 2019 Pages: 1804 - 1805
“Can’t seem to keep my mind to it”: did Arthur Miller’s Salesman have dementia with Lewy bodies? Conor FearonJohn-Paul TaylorSean O’Dowd Letter to the Editors 30 April 2019 Pages: 1806 - 1808
Anticholinergic drug usage and cognitive impairment: findings from three large European cohort studies Mo HuTom Hughes Journal club 13 June 2019 Pages: 1816 - 1818
James Crichton-Browne (1840–1938) Marco Cambiaghi Pioneers in Neurology 04 October 2018 Pages: 1819 - 1820